These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17663792)

  • 41. Kinetic analysis reveals that independent nucleation events determine the progression of polyglutamine aggregation in
    Sinnige T; Meisl G; Michaels TCT; Vendruscolo M; Knowles TPJ; Morimoto RI
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reversible Regulation of Polyubiquitin Gene
    Han SW; Jung BK; Park SH; Ryu KY
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progressive disruption of cellular protein folding in models of polyglutamine diseases.
    Gidalevitz T; Ben-Zvi A; Ho KH; Brignull HR; Morimoto RI
    Science; 2006 Mar; 311(5766):1471-4. PubMed ID: 16469881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. E2 enzymes: expanding the 'ubi-verse' of immune signaling.
    Ma A; Turer E
    Nat Immunol; 2006 Sep; 7(9):903-4. PubMed ID: 16924251
    [No Abstract]   [Full Text] [Related]  

  • 45. UBE2A/B is the trans-acting factor mediating mechanotransduction and contact inhibition.
    Feng M; Wang J; Li K; Nakamura F
    Biochem J; 2023 Oct; 480(20):1659-1674. PubMed ID: 37818922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Filter Retardation Assay for Detecting and Quantifying Polyglutamine Aggregates Using
    Sin O; Mata-Cabana A; Seinstra RI; Nollen EAA
    Bio Protoc; 2018 Oct; 8(19):. PubMed ID: 30450365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Individual point mutations in two ERAD E2 ubiquitin-conjugating enzymes do not affect
    Oswald M; Hulsey-Vincent H; Dahlberg CL
    MicroPubl Biol; 2020 Nov; 2020():. PubMed ID: 33274319
    [No Abstract]   [Full Text] [Related]  

  • 48. Polyglutamine makes the switch.
    Mushegian AA
    Sci Signal; 2017 Mar; 10(472):. PubMed ID: 28351951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polyglutamine stretches suppress transcription.
    Osborne LR
    Mol Med Today; 2000 Dec; 6(12):457-8. PubMed ID: 11099946
    [No Abstract]   [Full Text] [Related]  

  • 50. Ubiquitin-modifying enzymes in Huntington's disease.
    Sap KA; Geijtenbeek KW; Schipper-Krom S; Guler AT; Reits EA
    Front Mol Biosci; 2023; 10():1107323. PubMed ID: 36926679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduction of HIP2 expression causes motor function impairment and increased vulnerability to dopaminergic degeneration in Parkinson's disease models.
    Su J; Huang P; Qin M; Lu Q; Sang X; Cai Y; Wang Y; Liu F; Wu R; Wang X; Jiang X; Wang J; Sun Q; Chen S; Xu J
    Cell Death Dis; 2018 Oct; 9(10):1020. PubMed ID: 30282965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphological remodeling of
    Vayndorf EM; Scerbak C; Hunter S; Neuswanger JR; Toth M; Parker JA; Neri C; Driscoll M; Taylor BE
    NPJ Aging Mech Dis; 2016; 2():16001-. PubMed ID: 27347427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopamine signaling promotes the xenobiotic stress response and protein homeostasis.
    Joshi KK; Matlack TL; Rongo C
    EMBO J; 2016 Sep; 35(17):1885-901. PubMed ID: 27261197
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transiently transfected purine biosynthetic enzymes form stress bodies.
    Zhao A; Tsechansky M; Swaminathan J; Cook L; Ellington AD; Marcotte EM
    PLoS One; 2013; 8(2):e56203. PubMed ID: 23405267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of cytoprotective pathways is central to the extension of lifespan conferred by multiple longevity pathways.
    Shore DE; Carr CE; Ruvkun G
    PLoS Genet; 2012; 8(7):e1002792. PubMed ID: 22829775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ubiquitination is involved in secondary growth, not initial formation of polyglutamine protein aggregates in C. elegans.
    Skibinski GA; Boyd L
    BMC Cell Biol; 2012 Apr; 13():10. PubMed ID: 22494772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. UEV-1 is an ubiquitin-conjugating enzyme variant that regulates glutamate receptor trafficking in C. elegans neurons.
    Kramer LB; Shim J; Previtera ML; Isack NR; Lee MC; Firestein BL; Rongo C
    PLoS One; 2010 Dec; 5(12):e14291. PubMed ID: 21179194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. E1 ubiquitin-activating enzyme UBA-1 plays multiple roles throughout C. elegans development.
    Kulkarni M; Smith HE
    PLoS Genet; 2008 Jul; 4(7):e1000131. PubMed ID: 18636104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroprotection for Huntington's disease: ready, set, slow.
    Hersch SM; Rosas HD
    Neurotherapeutics; 2008 Apr; 5(2):226-36. PubMed ID: 18394565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ubiquitin conjugating enzymes participate in polyglutamine protein aggregation.
    Howard RA; Sharma P; Hajjar C; Caldwell KA; Caldwell GA; du Breuil R; Moore R; Boyd L
    BMC Cell Biol; 2007 Jul; 8():32. PubMed ID: 17663792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.